Galapagos’ innovative decentralized manufacturing approach streamlines CAR T-cell production, reducing costs associated with traditional manufacturing sites. These decentralized manufacturing units (DMUs) have been established in Europe and are expanding to the United States. The Boston-based DMU is already producing CAR T-cells for a Phase 2 study targeting various B-cell malignancies. By decentralizing manufacturing, Galapagos is […]
Category: cell manufacturing
Revolutionary Acquisition: STEMCELL Technologies and Cellular Highways Join Forces
STEMCELL Technologies, Canada’s leading biotechnology company, has acquired Cellular Highways Ltd, a UK-based biotech company specializing in advanced cell sorting technologies for cell and gene therapy, drug discovery, and general cell research. The acquisition includes the innovative Highway1 instrument, featuring Cellular Highways’ VACS™ technology, which enhances cell processing efficiency and maintains high cell integrity, reducing […]
Trump Tariffs Threaten Rare Disease Therapies
The risk posed by Trump tariffs on rare disease, cell, and gene therapies is a concern for the industry. With over 10,000 rare diseases lacking FDA-approved therapies, preserving incentives is crucial for public health. BioMarin, a company with approved gene therapies like Roctavian for hemophilia A, emphasizes the need to sustain innovation in this ecosystem […]
Advancements in Cell Manufacturing
Cell manufacturing refers to the process of producing cells for various applications in biotechnology and medicine. This includes the cultivation, expansion, and differentiation of cells to create products such as cell therapies, vaccines, and bioengineered tissues. With the increasing demand for personalized medicine and regenerative therapies, advancements in cell manufacturing are crucial for meeting these […]
Efficient Decentralized CAR T-Cell Manufacturing
Galapagos’ innovative decentralized manufacturing approach streamlines CAR T-cell production, reducing costs associated with traditional manufacturing sites. These decentralized manufacturing units (DMUs) have been established in Europe and are expanding to the United States. The Boston-based DMU is already producing CAR T-cells for a Phase 2 study targeting various B-cell malignancies. By decentralizing manufacturing, Galapagos is […]
Revolutionary Acquisition: STEMCELL Technologies and Cellular Highways Join Forces
STEMCELL Technologies, Canada’s leading biotechnology company, has acquired Cellular Highways Ltd, a UK-based biotech company specializing in advanced cell sorting technologies for cell and gene therapy, drug discovery, and general cell research. The acquisition includes the innovative Highway1 instrument, featuring Cellular Highways’ VACS™ technology, which enhances cell processing efficiency and maintains high cell integrity, reducing […]
Trump Tariffs Threaten Rare Disease Therapies
1 The risk posed by Trump tariffs on rare disease, cell, and gene therapies is a concern for the industry. With over 10,000 rare diseases lacking FDA-approved therapies, preserving incentives is crucial for public health. BioMarin, a company with approved gene therapies like Roctavian for hemophilia A, emphasizes the need to sustain innovation in this […]
Advancements in Cell Manufacturing
Cell manufacturing refers to the process of producing cells for various applications in biotechnology and medicine. This includes the cultivation, expansion, and differentiation of cells to create products such as cell therapies, vaccines, and bioengineered tissues. With the increasing demand for personalized medicine and regenerative therapies, advancements in cell manufacturing are crucial for meeting these […]
